Develops transdermal patches for opioid addiction.
Jul 2026Revenue $1.62M/yrExpenses $8.66M/yr
No trendCash runway ≈ 11 months from Jul 2026
Figures by year
When will NutriBand be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jul 2026, revenue was $1.62M and expenses $8.66M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jan 2026 | $2.04M | $10.4M | −$8.32M |
| Jan 2025 | $2.14M | $12.4M | −$10.3M |
| Jan 2024 | $2.09M | $6.96M | −$4.87M |
| Jan 2023 | $2.08M | $6.55M | −$4.48M |
| Jan 2022 | $1.42M | $7.53M | −$6.11M |
| Jan 2021 | $944K | $3.54M | −$2.60M |
| Jan 2020 | $371K | $2.34M | −$1.97M |
| Jan 2019 | $245K | $3.58M | −$3.33M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.